SerpinA3k Deficiency Ameliorates Experimental type 2 Diabetes
Cellular and Molecular Life Sciences · 2025
DOI: 10.1007/s00018-025-05922-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Life Sciences, 2025. Verfasst von Isaac González-Soria und 11 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Nacional Autónoma de México, Mexico City, Mexico. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Serpins, Diabetes Mellitus, Experimental. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes (T2D), a growing global health concern, is often exacerbated by obesity and is linked to severe complications. Serpins, a superfamily of serine protease inhibitors, that includes SerpinA3 in humans and its homolog SerpinA3k in mice. SerpinA3k regulates angiogenesis, reactive oxygen species (ROS) production, inflammation, and fibrosis particularly in the context of experimental ocular injury. Furthermore, we have previously demonstrated that urinary SerpinA3 serves as an early biomarker of kidney damage, including diabetic nephropathy; however, its functional role in renal damage, obesity, and T2D remains largely unexplored. This study explored the impact of SerpinA3k deficiency on obesity and T2D and its associated metabolic dysfunctions. Wild-type (WT, n = 27) and SerpinA3k knockout (KO n = 26) male mice were randomly assigned to three groups: standard chow diet (SD), high-fat diet (HFD) to induce obesity, and HFD combined with streptozotocin to induce T2D (D2). All the mice were followed and studied after 27 weeks. As expected, WT + D2 mice presented severe hyperglycemia, hyperinsulinemia, increased fat tissue, visceral adipocyte hypertrophy, and renal hyperfiltration. In sharp contrast, diabetic SerpinA3k-deficient mice were protected against these alterations, displaying improved glycemic control, greater pancreatic insulin content, reduced insulin resistance, and favorable adipocyte size remodeling characterized by a lower proportion of medium and large adipocytes. Additionally, these mice showed preserved lipolytic function, and attenuated renal hyperfiltration. Our findings indicate that targeting SerpinA3k mitigates hyperglycemia and insulin resistance, preserves adipose tissue functionality, and potentially prevents metabolic complications. These results highlight SerpinA3k as a promising therapeutic target for T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidad Nacional Autónoma de México, Mexico City, Mexico.
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- (PECEM) Program, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
- Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, Mexico.
- Universidad Nacional Autónoma de México, Mexico City, Mexico. norma.bobadillas@incmnsz.mx.
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. norma.bobadillas@incmnsz.mx.
Förderung
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
Zitieren
APA
González-Soria, I., Palacios-Brito, E., Gómez-Trujillo, D., Barragán-Jiménez, K., Soto-Valadez, A. D., Martínez-Rojas, M. A., Oliva-García, D., Aranda, J., Pérez-Villalva, R., López-Griego, L., Díaz-Villaseñor, A., & Bobadilla, N. A. (2025). SerpinA3k Deficiency Ameliorates Experimental type 2 Diabetes. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-025-05922-3
Vancouver
González-Soria I, Palacios-Brito E, Gómez-Trujillo D, Barragán-Jiménez K, Soto-Valadez AD, Martínez-Rojas MA, et al. SerpinA3k Deficiency Ameliorates Experimental type 2 Diabetes. Cellular and Molecular Life Sciences. 2025. doi:10.1007/s00018-025-05922-3
BibTeX
@article{GonzlezSoria2025,
author = {González-Soria, Isaac and Palacios-Brito, Esmeralda and Gómez-Trujillo, Dulce and Barragán-Jiménez, Karla and Soto-Valadez, Axel D and Martínez-Rojas, Miguel Angel and Oliva-García, Daniel and Aranda, Jorge and Pérez-Villalva, Rosalba and López-Griego, Lorena and Díaz-Villaseñor, Andrea and Bobadilla, Norma A},
title = {SerpinA3k Deficiency Ameliorates Experimental type 2 Diabetes},
journal = {Cellular and Molecular Life Sciences},
year = {2025},
doi = {10.1007/s00018-025-05922-3}
}
EUVIMED